VTGN - ビスタジェン・セラピュ―ティクス (VistaGen Therapeutics Inc.)

VTGNのニュース

   Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG)  2023/02/27 17:18:37 Stock Equity
VTGN has seen its SMA50 which is now 4.46%. In looking the SMA 200 we see that the stock has seen a -51.87%. SDIG has seen its SMA50 which is … The post Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG) appeared first on Stocks Equity .
   Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN)  2023/02/24 18:16:15 Stock Equity
UPST has seen its SMA50 which is now 6.82%. In looking the SMA 200 we see that the stock has seen a -29.92%. VTGN has seen its SMA50 which is … The post Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN) appeared first on Stocks Equity .
   Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89%  2023/02/22 15:30:00 Stocks Register
VistaGen Therapeutics Inc. (NASDAQ:VTGN) price closed lower on Tuesday, February 21, dropping -9.19% below its previous close. A look at the daily price movement shows that the last close reads $0.20, with intraday deals fluctuated between $0.177 and $0.193. The company’s 5Y monthly beta was ticking 1.03. Taking into account the 52-week price action we … Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89% Read More »
   Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%)  2023/02/21 18:39:49 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%) appeared first on Stocks Equity .
   Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%)  2023/02/14 04:21:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%) appeared first on Stocks Equity .
   Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG)  2023/02/27 17:18:37 Stock Equity
VTGN has seen its SMA50 which is now 4.46%. In looking the SMA 200 we see that the stock has seen a -51.87%. SDIG has seen its SMA50 which is … The post Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG) appeared first on Stocks Equity .
   Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN)  2023/02/24 18:16:15 Stock Equity
UPST has seen its SMA50 which is now 6.82%. In looking the SMA 200 we see that the stock has seen a -29.92%. VTGN has seen its SMA50 which is … The post Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN) appeared first on Stocks Equity .
   Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89%  2023/02/22 15:30:00 Stocks Register
VistaGen Therapeutics Inc. (NASDAQ:VTGN) price closed lower on Tuesday, February 21, dropping -9.19% below its previous close. A look at the daily price movement shows that the last close reads $0.20, with intraday deals fluctuated between $0.177 and $0.193. The company’s 5Y monthly beta was ticking 1.03. Taking into account the 52-week price action we … Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89% Read More »
   Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%)  2023/02/21 18:39:49 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%) appeared first on Stocks Equity .
   Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%)  2023/02/14 04:21:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%) appeared first on Stocks Equity .
   Is VistaGen Therapeutics Inc. (NASDAQ) Bullish Or Bearish In 2022?  2022/10/28 14:30:00 Stocks Register
VistaGen Therapeutics Inc. (NASDAQ:VTGN) shares, rose in value on Thursday, 10/27/22, with the stock price up by 6.71% to the previous day’s close as strong demand from buyers drove the stock to $0.12. Actively observing the price movement in the last trading, the stock closed the session at $0.11, falling within a range of $0.1125 … Is VistaGen Therapeutics Inc. (NASDAQ) Bullish Or Bearish In 2022? Read More »
   Watch this stock’s price performance: VistaGen Therapeutics Inc. (NASDAQ:VTGN)  2022/10/07 16:48:00 US Post News
VistaGen Therapeutics Inc. (VTGN)’s stock is trading at $0.15 at the moment marking a fall of -4.46% from the last session close. As of this writing, shares are priced at -94.42% less than their 52-week high of $2.69, and 8.07% over their 52-week low of $0.14. Based on the past 30-day period, the stock price […]
   Vistagen Announces the Two Leading Proxy Advisory Firms, Institutional Shareholder Services and Glass Lewis, Recommend Stockholders Vote “FOR” Proposal No. 5 to Provide its Board with the Option to Implement a Future Reverse Stock Split, if Necessary  2022/10/06 12:30:00 Wallstreet:Online
Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that the two leading independent proxy advisory firms, Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co. (Glass Lewis),
   Wondrous stocks: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -4.86%), Nielsen Holdings plc (NYSE:NLSN 0.11%)  2022/09/20 23:59:03 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Wondrous stocks: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -4.86%), Nielsen Holdings plc (NYSE:NLSN 0.11%) appeared first on Stocks Equity .
   Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday''s Mid-Day Session  2022/09/14 16:28:41 Benzinga
Gainers Akerna Corp. (NASDAQ: KERN ) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday. SciSparc Ltd. (NASDAQ: SPRC ) gained 68% to $1.3101 after the company announced it entered into an agreement to acquire Wellution for $20 million. bioAffinity Technologies, Inc. (NASDAQ: BIAF ) shares jumped 51.2% to $6.27 after the company announced publication of its research in high-throughput flow cytometry analysis of sputum in PLOS ONE. My Size, Inc. (NASDAQ: MYSZ ) rose 44% to $0.3194. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) surged 36.8% to $0.3090. Avenue Therapeutics, Inc. (NASDAQ: ATXI ) jumped 28.6% to $0.2992. Fast Radius, Inc. (NASDAQ: FSRD ) gained 23.6% to $0.6799. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) rose 23% to $2.2269. VistaGen Therapeutics, Inc. (NASDAQ: VTGN ) jumped 19.6% to $0.2259. VistaGen Therapeutics recently announced the completion of an interim analysis of its PALISADE-2 Phase 3 clinical trial of PH94B. Tenax Therapeutics, Inc. (NASDAQ: TENX ) surged 18% to $0.24.

calendar